Our recognition
Latest stories
Featured
Hikma delivers strong 2023 performance and a positive outlook for 2024
Press Release, Financial Results
- Hikma launches Diazepam Injection, USP in the US Press Release, Product 08 July 2026 Hikma launches Diazepam Injection, USP in the US
- Hikma launches XCOPRI® (Cenobamate tablets) in the UAE Press Release, Product 06 July 2026 Hikma launches XCOPRI® (Cenobamate tablets) in the UAE
- Hikma welcomes FDA approval of Guardant360® Liquid CDx Press Release, Product 22 June 2026 Hikma welcomes FDA approval of Guardant360® Liquid CDx
- Behind Better Health: Hikma's People Insight, Life at Hikma 22 June 2026 Behind Better Health: Hikma's People
Related content